Fatma Akyel

Fatma Akyel

Auto-generated profile, based on publicly available information

Fatma Akyel

Araç State Hospital

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2025 in Cukurova Medical Journal
Verified
Journal Article
Open access
AKAyhan Kars
Ayhan Kars
FAFatma Atalay
Fatma Atalay
KTKubra Topal
Kubra Topal
SASezai Sacid Anbar
Sezai Sacid Anbar
FAFatma Akyel
Fatma Akyel
KKKorhan Kilic
Korhan Kilic
Purpose: This research was conducted to assess cervical vestibular evoked myogenic potential (cVEMP) test responses in patients with primary hypothyroidism without vestibular symptoms. Materials and Methods: Thirty-one patients diagnosed with primary hypothyroidism and who had not yet started on hormone replacement therapy, together with a 26-member control group, were enrolled in the research. All participants underwent detailed otorhinolaryngological examinations and thyroid function, cVEMP, and audiological tests. cVEMP records were compared between the groups. Results: Thirty-one patients aged between 21 and 57 years (38.5±9.7) and a control group of 26 healthy volunteers aged between 20 and 52 years (36.1±8.8) were included in the study. Absent VEMP responses were observed in 12 members of the patient group and in three of the control group. Interpeak amplitudes (IPAs) in both ears were significantly lower in the patient group than in the controls. While no significant difference was found between the groups’ VEMP threshold values, asymmetry rates in both ears were significantly higher in the patient group. Conclusion: cVEMP can be usefully employed in the detection of subclinical

21 June 2022
Verified
Journal Article
Closed access
MKMiraç KOÇ
Miraç KOÇ
HKHatice Karabulut
Hatice Karabulut
ÖÖÖzgür Önen
Özgür Önen
FAFatma Akyel
Fatma Akyel
FGFatma Mutlu Kukul Güven
Fatma Mutlu Kukul Güven
Colchicine is used in the treatment of many diseases. It should be used very carefully as the treatment dose and toxic dose are very close to each other and may lead to multiorgan failure. Although colchicine toxicity is usually seen in suicidal use, it may also occur when used in therapeutic doses. In this report, we present a case of a 70-year-old patient who used colchicine due to pericardial effusion over two months and died from multiorgan failure, to draw attention to colchicine toxicity due to using it in therapeutic doses.